Adrienne I. Victor

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Ari M. Vanderwalde, Shay Bellasea, Kari Kendra et al. · Nature Medicine · 2023 · 167 citations · Full text

Life Sciences, Immunology, Oncology +14

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Megan Othus, Sandip Pravin Patel, Chris Ryan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Activation of adenosine A3 receptors reduces ischemic brain injury in rodents

Guann‐Juh Chen, Brandon K. Harvey, Hui Shen et al. · Journal of Neuroscience Research · 2006 · 106 citations

Medicine, Neuroscience, Pharmacology +17

Management of melanoma in patients with chronic lymphocytic leukemia

William J. Archibald, Philip J. Meacham, AnnaLynn M. Williams et al. · Leukemia Research · 2018 · 38 citations

Medicine, Hematology, Oncology +12

Immune checkpoint inhibitors in older adults with melanoma or cutaneous malignancies: The Wilmot Cancer Institute experience

William J. Archibald, Adrienne I. Victor, Myla Strawderman et al. · Journal of Geriatric Oncology · 2019 · 35 citations

Medicine, Dermatology, Oncology +17